Scarica l'app Stockscreener
7.97
0.38%
0.03
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXST Giù?
Forum
Previsione
Precedente Chiudi:
$7.94
Aprire:
$8
Volume 24 ore:
776.08K
Relative Volume:
0.61
Capitalizzazione di mercato:
$323.88M
Reddito:
$128.29M
Utile/perdita netta:
$-30.69M
Rapporto P/E:
-9.7195
EPS:
-0.82
Flusso di cassa netto:
$-27.17M
1 W Prestazione:
+8.44%
1M Prestazione:
-39.53%
6M Prestazione:
-75.46%
1 anno Prestazione:
-82.41%
Intervallo 1D:
$7.71
$8.09
Intervallo di 1 settimana:
$7.24
$8.095
Portata 52W:
$6.32
$58.23
Rxsight Inc Stock (RXST) Company Profile
Nome
Rxsight Inc
Settore
Industria
Telefono
949-521-7822
Indirizzo
100 COLUMBIA STREET, ALISO VIEJO
Confronta RXST con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
7.97 | 322.66M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.69B | 4.15B | 623.10M | 6.95 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-15 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Downgrade | Jefferies | Buy → Hold |
| 2025-07-09 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-07-09 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Iniziato | Piper Sandler | Neutral |
| 2025-04-09 | Downgrade | UBS | Buy → Neutral |
| 2025-04-04 | Downgrade | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Downgrade | BofA Securities | Buy → Underperform |
| 2024-12-20 | Downgrade | Stifel | Buy → Hold |
| 2024-12-11 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Iniziato | UBS | Buy |
| 2024-10-29 | Iniziato | Jefferies | Buy |
| 2024-08-20 | Reiterato | Needham | Buy |
| 2024-08-06 | Reiterato | Needham | Buy |
| 2024-05-07 | Reiterato | BTIG Research | Buy |
| 2023-12-13 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Iniziato | Stifel | Buy |
| 2023-12-04 | Iniziato | Morgan Stanley | Overweight |
| 2023-04-13 | Iniziato | Oppenheimer | Outperform |
| 2022-12-12 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Iniziato | Needham | Buy |
Mostra tutto
Rxsight Inc Borsa (RXST) Ultime notizie
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - WV News
Important Notice to Long-Term Shareholders of Alto - GlobeNewswire
Important Notice to Long-Term Shareholders of Alto Neuroscience, Inc. (NYSE: ANRO); Luminar Technologies, Inc. (NASDAQ: LAZR); Replimune Group, Inc. (NASDAQ: REPL); and RxSight, Inc. (NASDAQ: RXST): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Class Action Filed Against RxSight, Inc. (RXST) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Securities Fraud in the Biotech Sector: Evaluating Risks and Governance Gaps at RxSight (RXST) - AInvest
RXST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
RXST STOCK UPDATE: RxSight, Inc. (NASDAQ:RXST) is being - GlobeNewswire
RxSight INVESTOR ALERT: Edelson Lechtzin LLP Urges RxSight, - GlobeNewswire
Corporate Governance Failures and Shareholder Risks at RxSight, Inc. (RXST): A Cautionary Tale for the Medtech Sector - AInvest
Join Class Action to Recover Losses from RxSight, Inc. (RXST)Contact Levi & Korsinsky Before September 22, 2025 - ACCESS Newswire
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve
Lost Money on RxSight, Inc. (RXST)? Urged to Join Class Action Before September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
RXST Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against RxSight, Inc. - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - Business Wire
Deadline Approaching: RxSight, Inc. (RXST) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith - FinancialContent
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsRXST - Lelezard
Is RxSight Inc. stock overhyped or has real potentialUnrivaled growth potential - jammulinksnews.com
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire
RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 - Nasdaq
Contact Levi & Korsinsky by September 22, 2025 to Join Class Action Against RxSight, Inc. (RXST) - TradingView
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - The Globe and Mail
RxSight Faces Class Action for Alleged Fraud - TipRanks
RXST CLASS ACTION: Decline in LAL Utilization leads to - GlobeNewswire
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
What analysts say about RxSight Inc. stockTriple-digit growth rates - Autocar Professional
Medical Device Co. Faces Investor Suit Over Sales Decline - Law360
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
RXSIGHT ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
Is RxSight Inc. a good long term investmentSignificant capital appreciation - jammulinksnews.com
RXST INVESTOR ALERT: RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
RXST ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. Investors - TradingView
RxSight, Inc. Investors: Company Investigated by the Portnoy Law Firm - GlobeNewswire
RXST LEGAL UPDATE: RxSight, Inc. Sued for Fraud Amid Declining LAL Utilization -- Investors with Losses are Notified to Contact BFA Law before September 22 Class Action Deadline - Business Wire
What drives RxSight Inc. stock priceDynamic capital growth - Autocar Professional
RXST Investors with Losses in Excess of $100K Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - MarketScreener
RxSight Investor Sues After 2025 Revenue Cut on Eye Device Sales - Bloomberg Law News
Law Offices of Frank R. Cruz Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action - The Globe and Mail
Law Offices of Howard G. Smith Encourages RxSight, Inc. (RXST) Investors To Inquire About Securities Fraud Class Action - The Globe and Mail
Rosen Law Firm Urges RxSight, Inc. (NASDAQ: RXST) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Globe and Mail
RXSIGHT, INC. (NASDAQ: RXST) INVESTOR ALERT Investors With - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc.RXST - FinancialContent
Shareholders Filed a Lawsuit Against RxSight for Overstating Demand - TradingView
RxSight ($RXST) Sales Execution Failures, Guidance Cut, and Executive Turnover Case - TradingView
Shareholder Alert: Robbins LLP Informs Investors of the RxSight,Inc. Securities Fraud Class Action Lawsuit - ACCESS Newswire
RXST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
RXST LOSS ALERT: Lose Money on RxSight, Inc. (NASDAQ: - GlobeNewswire
RxSight Shares Fall 38% on Q2 ‘Underperformance’ - Orange County Business Journal
RXST Investors Have Opportunity to Join RxSight, Inc. Fraud Investigation with the Schall Law Firm - ETX View
Rxsight Inc Azioni (RXST) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Rxsight Inc Azioni (RXST) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B | See remarks |
Apr 14 '25 |
Option Exercise |
4.34 |
7,792 |
33,806 |
38,354 |
| Fountain Tamara | Director |
Mar 12 '25 |
Sale |
25.71 |
7,000 |
180,002 |
24,793 |
1.27%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):